Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
77.6M
-
Number of holders
-
276
-
Total shares
-
66.1M
-
Shares change
-
-577K
-
Total reported value, excl. options
-
$2.88B
-
Value change
-
-$21.4M
-
Put/Call ratio
-
0.38
-
Number of buys
-
121
-
Number of sells
-
-129
-
Price
-
$43.55
Significant Holders of INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART) as of Q4 2023
275 filings reported holding IART - INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock as of Q4 2023.
INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART) has 276 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66.1M shares
of 77.6M outstanding shares and own 85.18% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (7.01M shares), BlackRock Inc. (6.64M shares), MORGAN STANLEY (5.27M shares), Capital Research Global Investors (4.3M shares), WELLINGTON MANAGEMENT GROUP LLP (3.19M shares), COOKE & BIELER LP (2.83M shares), ALLIANCEBERNSTEIN L.P. (2.73M shares), Clearbridge Investments, LLC (2.47M shares), Champlain Investment Partners, LLC (2.44M shares), and STATE STREET CORP (2.12M shares).
This table shows the top 276 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.